investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Immunophysiological Mechanisms in the Biological Therapy of Cancer

Robert Wiltrout

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
The goal is to evaluate the anti-tumor and immunomodulatory potential of AstraZeneca's proprietary compounds, AZD8055 (mTOR blocker) and AZD2171 (VEGF blocker).

Related projects

Robert Gillies

Research on the Effects of Tumor Acidity on Macrophage Infiltration and Activation

All cancers but non-melanoma skin cancer

George Pavlakis

DNA Vaccines

All cancers but non-melanoma skin cancer

Pathology

Binghui Shen

Dynamic Functions of DNA2 Counteract DNA Replication Stresses and Tumorigenesis

All cancers but non-melanoma skin cancer

Radiation Oncology

Gajanana Datta

Improved metabolic imaging using hyperpolarized 13C MR substrates

All cancers but non-melanoma skin cancer

Evripidis Gavathiotis

Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy

All cancers but non-melanoma skin cancer

Allan Weissman

Enzymes and Substrates of the Ubiquitin Conjugating System

All cancers but non-melanoma skin cancer

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

All cancers but non-melanoma skin cancer

Teresita Munoz-Antonia

Ponce School of Medicine – Moffitt Cancer Center Partnership

All cancers but non-melanoma skin cancer

Yubin Zhou

Molecular control of calcium influx at the ER-plasma membrane junctions

All cancers but non-melanoma skin cancer